Mair J - Search Results

1

Clinical applications of B-type natriuretic peptide (BNP) testing.

Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, Luchner A, McDonagh T, Mair J, Nieminen M, Francis G. Cowie MR, et al. Among authors: mair j. Eur Heart J. 2003 Oct;24(19):1710-8. doi: 10.1016/s0195-668x(03)00476-7. Eur Heart J. 2003. PMID: 14522565 Free article. Review.

2

The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.

Mair J, Hammerer-Lercher A, Puschendorf B. Mair J, et al. Clin Chem Lab Med. 2001 Jul;39(7):571-88. doi: 10.1515/CCLM.2001.093. Clin Chem Lab Med. 2001. PMID: 11522102 Review.

3

B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.

Hammerer-Lercher A, Mair J, Antretter H, Ruttmann E, Poelzl G, Laufer G, Puschendorf B, Hangler H. Hammerer-Lercher A, et al. Among authors: mair j. J Heart Lung Transplant. 2005 Sep;24(9):1444. doi: 10.1016/j.healun.2004.08.018. J Heart Lung Transplant. 2005. PMID: 16143273

4

Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?

Mair J, Lindahl B, Giannitsis E, Huber K, Thygesen K, Plebani M, Möckel M, Müller C, Jaffe AS; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Mair J, et al. Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):321-328. doi: 10.1177/2048872615626355. Epub 2016 Jan 12. Eur Heart J Acute Cardiovasc Care. 2017. PMID: 26758541

5

Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.

Jakob G, Mair J, Pichler M, Puschendorf B. Jakob G, et al. Among authors: mair j. Br Heart J. 1995 Feb;73(2):145-50. doi: 10.1136/hrt.73.2.145. Br Heart J. 1995. PMID: 7696024 Free PMC article.

6

Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.

Friedl W, Mair J, Thomas S, Pichler M, Puschendorf B. Friedl W, et al. Among authors: mair j. Heart. 1996 Aug;76(2):129-36. doi: 10.1136/hrt.76.2.129. Heart. 1996. PMID: 8795474 Free PMC article.

7

Natriuretic peptides in assessment of left-ventricular dysfunction.

Mair J, Friedl W, Thomas S, Puschendorf B. Mair J, et al. Scand J Clin Lab Invest Suppl. 1999;230:132-42. Scand J Clin Lab Invest Suppl. 1999. PMID: 10389212 Review.

8

Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction.

Hammerer-Lercher A, Neubauer E, Müller S, Pachinger O, Puschendorf B, Mair J. Hammerer-Lercher A, et al. Among authors: mair j. Clin Chim Acta. 2001 Aug 20;310(2):193-7. doi: 10.1016/s0009-8981(01)00578-2. Clin Chim Acta. 2001. PMID: 11498085

9

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study.

Wu AH, Packer M, Smith A, Bijou R, Fink D, Mair J, Wallentin L, Johnston N, Feldcamp CS, Haverstick DM, Ahnadi CE, Grant A, Despres N, Bluestein B, Ghani F. Wu AH, et al. Among authors: mair j. Clin Chem. 2004 May;50(5):867-73. doi: 10.1373/clinchem.2003.026138. Epub 2004 Mar 9. Clin Chem. 2004. PMID: 15010423

10

Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.

Hammerer-Lercher A, Ludwig W, Falkensammer G, Müller S, Neubauer E, Puschendorf B, Pachinger O, Mair J. Hammerer-Lercher A, et al. Among authors: mair j. Clin Chem. 2004 Jul;50(7):1174-83. doi: 10.1373/clinchem.2003.028316. Epub 2004 May 13. Clin Chem. 2004. PMID: 15142976

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page